423 related articles for article (PubMed ID: 25300471)
1. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
Kawaura K; Koike H; Kinoshita K; Kambe D; Kaku A; Karasawa J; Chaki S; Hikichi H
Behav Brain Res; 2015 Feb; 278():186-92. PubMed ID: 25300471
[TBL] [Abstract][Full Text] [Related]
2. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
Karasawa J; Hashimoto K; Chaki S
Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
[TBL] [Abstract][Full Text] [Related]
3. D-Serine and a glycine transporter-1 inhibitor enhance social memory in rats.
Shimazaki T; Kaku A; Chaki S
Psychopharmacology (Berl); 2010 Apr; 209(3):263-70. PubMed ID: 20198471
[TBL] [Abstract][Full Text] [Related]
4. Modulation of striatal dopamine release in vitro by agonists of the glycineB site of NMDA receptors; interaction with antipsychotics.
Bennett S; Gronier B
Eur J Pharmacol; 2005 Dec; 527(1-3):52-9. PubMed ID: 16307739
[TBL] [Abstract][Full Text] [Related]
5. Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia.
Boulay D; Pichat P; Dargazanli G; Estenne-Bouhtou G; Terranova JP; Rogacki N; Stemmelin J; Coste A; Lanneau C; Desvignes C; Cohen C; Alonso R; Vigé X; Biton B; Steinberg R; Sevrin M; Oury-Donat F; George P; Bergis O; Griebel G; Avenet P; Scatton B
Pharmacol Biochem Behav; 2008 Nov; 91(1):47-58. PubMed ID: 18621075
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex.
Konradsson A; Marcus MM; Hertel P; Svensson TH; Jardemark KE
Synapse; 2006 Aug; 60(2):102-8. PubMed ID: 16715496
[TBL] [Abstract][Full Text] [Related]
7. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1).
Manahan-Vaughan D; Wildförster V; Thomsen C
Eur J Neurosci; 2008 Oct; 28(7):1342-50. PubMed ID: 18973561
[TBL] [Abstract][Full Text] [Related]
8. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
Gaisler-Salomon I; Weiner I
Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
[TBL] [Abstract][Full Text] [Related]
9. Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7- dichloro-kynurenic acid, glycine site antagonists.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
Pol J Pharmacol; 1994; 46(3):115-24. PubMed ID: 8000442
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of system A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action.
Javitt DC; Duncan L; Balla A; Sershen H
Mol Psychiatry; 2005 Mar; 10(3):275-87. PubMed ID: 15278098
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic-like effects of the N-methyl-D-aspartate receptor modulator neboglamine: an immunohistochemical and behavioural study in the rat.
Chiusaroli R; Garofalo P; Espinoza S; Neri E; Caselli G; Lanza M
Pharmacol Res; 2010 May; 61(5):430-6. PubMed ID: 20045056
[TBL] [Abstract][Full Text] [Related]
12. Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia.
Lipina T; Labrie V; Weiner I; Roder J
Psychopharmacology (Berl); 2005 Apr; 179(1):54-67. PubMed ID: 15759151
[TBL] [Abstract][Full Text] [Related]
13. The effects of glycine transporter I inhibitor, N-methylglycine (sarcosine), on ketamine-induced alterations in sensorimotor gating and regional brain c-Fos expression in rats.
Yang SY; Hong CJ; Huang YH; Tsai SJ
Neurosci Lett; 2010 Jan; 469(1):127-30. PubMed ID: 19944746
[TBL] [Abstract][Full Text] [Related]
14. Modulation of striatal dopamine release by glycine transport inhibitors.
Javitt DC; Hashim A; Sershen H
Neuropsychopharmacology; 2005 Apr; 30(4):649-56. PubMed ID: 15688094
[TBL] [Abstract][Full Text] [Related]
15. Ketamine-enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia.
Chindo BA; Adzu B; Yahaya TA; Gamaniel KS
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):310-6. PubMed ID: 22561603
[TBL] [Abstract][Full Text] [Related]
16. Effects of antipsychotic treatments and D-serine supplementation on the electrophysiological activation of midbrain dopamine neurons induced by the noncompetitive NMDA antagonist MK 801.
Bennett S; Gronier B
Synapse; 2007 Aug; 61(8):679-88. PubMed ID: 17523181
[TBL] [Abstract][Full Text] [Related]
17. Effects of MK-801 and antidepressant drugs in the forced swimming test in rats.
Maj J; Rogóz Z; Skuza G; Sowińska H
Eur Neuropsychopharmacol; 1992 Mar; 2(1):37-41. PubMed ID: 1638172
[TBL] [Abstract][Full Text] [Related]
18. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia.
Tsai G; Lane HY; Yang P; Chong MY; Lange N
Biol Psychiatry; 2004 Mar; 55(5):452-6. PubMed ID: 15023571
[TBL] [Abstract][Full Text] [Related]
19. The effects of combined treatment with MK-801 and antidepressant drugs in the forced swimming test in rats.
Maj J; Rogóz Z; Skuza G
Pol J Pharmacol Pharm; 1992; 44(3):217-26. PubMed ID: 1470560
[TBL] [Abstract][Full Text] [Related]
20. Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat.
López-Gil X; Babot Z; Amargós-Bosch M; Suñol C; Artigas F; Adell A
Neuropsychopharmacology; 2007 Oct; 32(10):2087-97. PubMed ID: 17356574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
